Market Closed -
Nasdaq Stockholm
11:29:59 2024-05-31 am EDT
|
5-day change
|
1st Jan Change
|
187
SEK
|
-1.01%
|
|
-2.09%
|
-16.63%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
47,392
|
52,322
|
107,613
|
58,914
|
61,092
|
50,933
|
-
|
-
|
Enterprise Value (EV)
1 |
56,158
|
56,472
|
111,222
|
61,516
|
69,104
|
57,336
|
55,313
|
52,828
|
P/E ratio
|
38.8
x
|
16.2
x
|
36.2
x
|
23.6
x
|
25.3
x
|
18.6
x
|
15.9
x
|
13.9
x
|
Yield
|
0.86%
|
1.56%
|
1.01%
|
1.96%
|
1.96%
|
2.54%
|
2.84%
|
3.19%
|
Capitalization / Revenue
|
1.78
x
|
1.75
x
|
3.98
x
|
2.08
x
|
1.92
x
|
1.5
x
|
1.43
x
|
1.36
x
|
EV / Revenue
|
2.11
x
|
1.89
x
|
4.11
x
|
2.17
x
|
2.17
x
|
1.69
x
|
1.55
x
|
1.41
x
|
EV / EBITDA
|
11.3
x
|
7.54
x
|
16.5
x
|
10.4
x
|
12.4
x
|
8.88
x
|
7.7
x
|
6.73
x
|
EV / FCF
|
21.5
x
|
9.18
x
|
19.8
x
|
32.4
x
|
43.1
x
|
17.6
x
|
15.1
x
|
12.8
x
|
FCF Yield
|
4.65%
|
10.9%
|
5.06%
|
3.08%
|
2.32%
|
5.67%
|
6.62%
|
7.82%
|
Price to Book
|
2.26
x
|
2.44
x
|
4.27
x
|
1.93
x
|
2.01
x
|
1.58
x
|
1.49
x
|
1.39
x
|
Nbr of stocks (in thousands)
|
272,370
|
272,370
|
272,370
|
272,370
|
272,370
|
272,370
|
-
|
-
|
Reference price
2 |
174.0
|
192.1
|
395.1
|
216.3
|
224.3
|
187.0
|
187.0
|
187.0
|
Announcement Date
|
1/30/20
|
1/28/21
|
1/28/22
|
2/1/23
|
2/1/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
26,559
|
29,819
|
27,049
|
28,292
|
31,827
|
33,945
|
35,711
|
37,384
|
EBITDA
1 |
4,986
|
7,487
|
6,754
|
5,891
|
5,574
|
6,456
|
7,185
|
7,845
|
EBIT
1 |
2,813
|
5,261
|
4,939
|
4,096
|
3,653
|
4,349
|
4,969
|
5,550
|
Operating Margin
|
10.59%
|
17.64%
|
18.26%
|
14.48%
|
11.48%
|
12.81%
|
13.92%
|
14.85%
|
Earnings before Tax (EBT)
1 |
1,909
|
4,485
|
4,188
|
3,472
|
3,343
|
3,834
|
4,513
|
5,137
|
Net income
1 |
1,222
|
3,239
|
2,970
|
2,491
|
2,412
|
2,791
|
3,249
|
3,699
|
Net margin
|
4.6%
|
10.86%
|
10.98%
|
8.8%
|
7.58%
|
8.22%
|
9.1%
|
9.89%
|
EPS
2 |
4.480
|
11.89
|
10.90
|
9.150
|
8.860
|
10.04
|
11.80
|
13.43
|
Free Cash Flow
1 |
2,612
|
6,154
|
5,630
|
1,897
|
1,604
|
3,254
|
3,661
|
4,129
|
FCF margin
|
9.83%
|
20.64%
|
20.81%
|
6.71%
|
5.04%
|
9.59%
|
10.25%
|
11.04%
|
FCF Conversion (EBITDA)
|
52.39%
|
82.2%
|
83.36%
|
32.2%
|
28.78%
|
50.4%
|
50.96%
|
52.63%
|
FCF Conversion (Net income)
|
213.75%
|
190%
|
189.56%
|
76.15%
|
66.5%
|
116.58%
|
112.68%
|
111.61%
|
Dividend per Share
2 |
1.500
|
3.000
|
4.000
|
4.250
|
4.400
|
4.755
|
5.308
|
5.965
|
Announcement Date
|
1/30/20
|
1/28/21
|
1/28/22
|
2/1/23
|
2/1/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
7,987
|
6,182
|
6,670
|
6,941
|
8,498
|
7,141
|
7,176
|
7,607
|
9,903
|
7,513
|
7,821
|
8,176
|
10,174
|
EBITDA
1 |
2,118
|
1,235
|
1,350
|
1,579
|
1,727
|
1,380
|
902
|
1,525
|
1,766
|
1,255
|
1,304
|
1,615
|
2,189
|
EBIT
1 |
1,652
|
797
|
913
|
1,121
|
1,265
|
921
|
442
|
1,047
|
1,243
|
784
|
817.5
|
1,123
|
1,692
|
Operating Margin
|
20.68%
|
12.89%
|
13.69%
|
16.15%
|
14.89%
|
12.9%
|
6.16%
|
13.76%
|
12.55%
|
10.44%
|
10.45%
|
13.73%
|
16.63%
|
Earnings before Tax (EBT)
1 |
1,075
|
749
|
867
|
1,075
|
781
|
826
|
305
|
1,227
|
986
|
638
|
624
|
869.2
|
1,421
|
Net income
1 |
771
|
534
|
603
|
798
|
556
|
586
|
214
|
894
|
718
|
459
|
443.4
|
621.5
|
1,016
|
Net margin
|
9.65%
|
8.64%
|
9.04%
|
11.5%
|
6.54%
|
8.21%
|
2.98%
|
11.75%
|
7.25%
|
6.11%
|
5.67%
|
7.6%
|
9.99%
|
EPS
2 |
2.830
|
1.960
|
2.210
|
2.930
|
2.040
|
2.150
|
0.7900
|
3.280
|
2.640
|
1.690
|
1.634
|
2.282
|
3.730
|
Dividend per Share
|
4.000
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
1/28/22
|
4/26/22
|
7/19/22
|
10/19/22
|
2/1/23
|
4/26/23
|
7/18/23
|
10/23/23
|
2/1/24
|
4/22/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
8,766
|
4,150
|
3,609
|
2,602
|
8,012
|
6,403
|
4,380
|
1,895
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.758
x
|
0.5543
x
|
0.5344
x
|
0.4417
x
|
1.437
x
|
0.9917
x
|
0.6097
x
|
0.2416
x
|
Free Cash Flow
1 |
2,612
|
6,154
|
5,630
|
1,897
|
1,604
|
3,254
|
3,661
|
4,129
|
ROE (net income / shareholders' equity)
|
6.2%
|
15.1%
|
12.9%
|
8.9%
|
7.8%
|
9.08%
|
9.89%
|
10.6%
|
ROA (Net income/ Total Assets)
|
2.77%
|
7.22%
|
6.63%
|
5.16%
|
4.74%
|
5.04%
|
5.69%
|
6.17%
|
Assets
1 |
44,116
|
44,863
|
44,785
|
48,294
|
50,889
|
55,375
|
57,137
|
59,980
|
Book Value Per Share
2 |
77.00
|
78.90
|
92.40
|
112.0
|
112.0
|
119.0
|
126.0
|
135.0
|
Cash Flow per Share
2 |
14.10
|
26.40
|
24.10
|
-
|
10.90
|
21.60
|
18.00
|
19.60
|
Capex
1 |
1,220
|
1,045
|
930
|
1,136
|
1,353
|
1,433
|
1,489
|
1,549
|
Capex / Sales
|
4.59%
|
3.5%
|
3.44%
|
4.02%
|
4.25%
|
4.22%
|
4.17%
|
4.14%
|
Announcement Date
|
1/30/20
|
1/28/21
|
1/28/22
|
2/1/23
|
2/1/24
|
-
|
-
|
-
|
Average target price
229.2
SEK Spread / Average Target +22.58% Consensus |
1st Jan change
|
Capi.
|
---|
| -16.63% | 4.84B | | +75.69% | 12.57B | | -24.68% | 7.34B | | +6.22% | 6.61B | | +12.58% | 5.39B | | +26.90% | 4.53B | | -21.14% | 3.91B | | -22.99% | 2.91B | | +47.42% | 2.37B | | -0.37% | 2B |
Medical Equipment
|